Clinical Trials on SARS-CoV 2 Infection in United States
Total 747 results
-
Boston UniversityNational Institute of Allergy and Infectious Diseases (NIAID); Burnet Institute and other collaboratorsRecruitingSARS CoV 2 Infection | SARS CoV 2 VaccinationUnited States, Malawi
-
BioNTech SECompletedCOVID-19 | SARS-CoV2 Infection | SARS-CoV-2 Acute Respiratory Disease | SARS (Disease)United States, Germany, Turkey, South Africa
-
Vaccine Company, Inc.Active, not recruitingSARS-CoV-2 | SARS-CoVUnited States
-
The Board of MedicineApollo Neuroscience, Inc.RecruitingPost-acute Sequelae of SARS-COV-2 InfectionUnited States
-
Stanford UniversityPfizerCompletedLong COVID | Post-acute Sequelae of SARS-CoV-2 InfectionUnited States
-
HyperSpectral APDSuspended
-
Sophia Koo, M.D.Massachusetts General Hospital; GlaxoSmithKline; Dana-Farber Cancer InstituteActive, not recruitingSARS CoV 2 InfectionUnited States
-
Indiana UniversityCompletedSARS-CoV-2United States
-
Enanta Pharmaceuticals, IncCompleted
-
Rutgers, The State University of New JerseyNational Institute of Dental and Craniofacial Research (NIDCR)Completed
-
Serpin Pharma, LLCUniversity of VirginiaTerminated
-
University of Wisconsin, MadisonCompleted
-
NYU Langone HealthRecruitingNeuropsychiatric Post-Acute Sequelae of SARS-CoV-2 InfectionUnited States
-
AIDAR Health, Inc.MAXIS, LLCWithdrawn
-
Rutgers, The State University of New JerseyNational Institute of Dental and Craniofacial Research (NIDCR)CompletedSARS-CoV2 InfectionUnited States
-
Sky Medical Supplies & Equipments, LLCRecruitingCOVID-19 | Sars-CoV-2 InfectionUnited States
-
Ascletis Pharmaceuticals Co., Ltd.Not yet recruitingSARS CoV 2 InfectionUnited States
-
Rutgers, The State University of New JerseyNational Institute of Dental and Craniofacial Research (NIDCR)Completed
-
NYU Langone HealthRecruitingCOVID-19 | SARS CoV 2 InfectionUnited States
-
ImunonRecruitingSARS CoV 2 InfectionUnited States
-
Colorado School of Public HealthUniversity of Colorado, Denver; University of Colorado, Boulder; Colorado State... and other collaboratorsRecruitingCOVID-19 | SARS-CoV2 InfectionUnited States
-
Mayo ClinicEnrolling by invitation
-
Michigan State UniversityJohns Hopkins University; National Cancer Institute (NCI)CompletedSARS-CoV2 InfectionUnited States
-
Michigan State UniversityJohns Hopkins University; National Cancer Institute (NCI)Active, not recruitingSARS-CoV2 InfectionUnited States
-
HDT BioKaiser Permanente; Rainier Clinical Research Center; C3 Research AssociatesActive, not recruitingSARS-CoV2 InfectionUnited States
-
MiCo BioMed Co., Ltd.SyntactxCompletedSARS-CoV2 InfectionUnited States
-
Johns Hopkins UniversityEiger BioPharmaceuticalsTerminatedSars-CoV-2 InfectionUnited States
-
Duke UniversityTerminated
-
University of MinnesotaWithdrawnPost-acute Sequelae SARS-CoV-2 Infection (PASC)United States
-
Ridgeback Biotherapeutics, LPMerck Sharp & Dohme LLCCompletedSARS-CoV 2United States
-
University of UtahCompletedSARS CoV-2 InfectionUnited States
-
TScan Therapeutics, Inc.CompletedIdentify the Viral Epitopes of Memory CD8 T Cells From Individuals That Have Recovered From SARS-CoV-2 Infection | Determine Which SARS-CoV-2 Proteins Are Frequently Recognized by T Cells in Patients With Varying HLA TypesUnited States
-
Family Health Centers of San DiegoActive, not recruitingChronic Fatigue Syndrome | SARS-CoV-2 Acute Respiratory Disease | Post COVID-19 Condition | Myalgic Encephalomyelitis | Post-acute Sequelae of SARS-COV-2 InfectionUnited States
-
Providence Health & ServicesOncoSec Medical IncorporatedCompleted
-
E25Bio, Inc.SCRI Development Innovations, LLCCompleted
-
PfizerCompletedCovid-19 | Immunocompromised | Breakthrough Infection | SARS-COV-2 Infection | SARS-COV-2 | ImmunosuppressedUnited States
-
GeneOne Life Science, Inc.TerminatedSARS-CoV 2 | InfectionUnited States
-
University of Southern CaliforniaNational Institute on Aging (NIA); AltaMed Health Services CorporationCompleted
-
ModernaTX, Inc.CompletedSARS-CoV-2United States
-
ModernaTX, Inc.Terminated
-
Leidos Life SciencesUnited States Department of DefenseActive, not recruitingCOVID-19 | Covid19 | Coronavirus Disease 2019 | SARS-CoV-2 Infection | SARS-CoV-2 Acute Respiratory Disease | COVID-19 Pandemic | COVID-19 Virus Infection | COVID-19 Virus Disease | 2019 Novel Coronavirus Disease | 2019 Novel Coronavirus Infection | 2019-nCoV Disease | 2019-nCoV InfectionUnited States
-
University of PennsylvaniaNot yet recruiting
-
ModernaTX, Inc.Aetion, Inc.Active, not recruiting
-
Convergent Genomics, Inc.Completed
-
ModernaTX, Inc.CompletedSARS-CoV-2United States
-
Illumina, Inc.Helix OpCo, LLCCompletedSARS-CoV-2United States
-
Ohio UniversityAmerican Osteopathic FoundationCompletedSARS-CoV2 Infection | COVID-19 Lower Respiratory InfectionUnited States
-
Alvea Holdings, LLCCompletedSars-CoV-2 InfectionSouth Africa
-
Ology BioservicesEnabling Biotechnologies (EB)CompletedSARS-CoV-2United States
-
Swedish Orphan BiovitrumTerminated